ConductScience.org, home

Paper9503276

Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis.

Rudolf J and 3 others. J Neural Transm (Vienna), 1997. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis. Papers, record 9503276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9503276

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis.
PubMed
Journal
J Neural Transm (Vienna)
PubMed
Year
1997
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.8
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rudolf JJ
2Grond MM
3Neveling MM
4Heiss WDW D

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AgranulocytosisMajor topic
Antiparkinson AgentsMajor topic
Antipsychotic AgentsMajor topic
ClozapineMajor topic
Dopamine AgentsMajor topic
Psychoses, Substance-InducedMajor topic
ThrombocytopeniaMajor topic
Aged
Humans
Leukocyte Count
Male
Parkinson Disease
Platelet Count

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18333909Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease.J Neural Transm Park Dis Dement Sect1993https://conductscience.org/library/papers/8333909PubMed
26067254Parkinsonism: onset, progression and mortality.Neurology1967https://conductscience.org/library/papers/6067254PubMed
37525542G-CSF and the management of clozapine-induced agranulocytosis.J Clin Psychiatry1994https://conductscience.org/library/papers/7525542PubMed
48894200Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.Br J Psychiatry1996https://conductscience.org/library/papers/8894200PubMed
51503676On the possible mechanisms and predictability of clozapine-induced agranulocytosis.Drug Saf1992https://conductscience.org/library/papers/1503676PubMed
68211341Platelet dysfunction associated with clozapine therapy.South Med J1993https://conductscience.org/library/papers/8211341PubMed
77898690Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease.Neurology1995https://conductscience.org/library/papers/7898690PubMed
87583621Role of serotonin in the action of atypical antipsychotic drugs.Clin Neurosci1995https://conductscience.org/library/papers/7583621PubMed
98515788Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.N Engl J Med1993https://conductscience.org/library/papers/8515788PubMed
105000569Psychiatric side effects of levodopa in man.JAMA1971https://conductscience.org/library/papers/5000569PubMed
116695602Mental disorders in Parkinson's disease after treatment with L-DOPA.Adv Neurol1984https://conductscience.org/library/papers/6695602PubMed
121350059Clozapine prevents recurrence of psychosis in Parkinson's disease.Mov Disord1992https://conductscience.org/library/papers/1350059PubMed
137872135Parkinson's disease: drug-induced psychiatric states.Adv Neurol1995https://conductscience.org/library/papers/7872135PubMed
145655944Critical analysis of the disability in Parkinson's disease.Mod Treat1968https://conductscience.org/library/papers/5655944PubMed
157766285Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease. A high potency effect of clozapine.Neuropsychopharmacology1995https://conductscience.org/library/papers/7766285PubMed
167782019[The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].Fortschr Neurol Psychiatr1995https://conductscience.org/library/papers/7782019PubMed
177856623Clozapine therapy for Parkinson's disease and other movement disorders.Am J Hosp Pharm1994https://conductscience.org/library/papers/7856623PubMed
188145929Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis.Neurology1994https://conductscience.org/library/papers/8145929PubMed
191503671A report of clozapine-induced agranulocytosis in the United States. Incidence and risk factors.Drug Saf1992https://conductscience.org/library/papers/1503671PubMed
203288717Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.J Neurol Neurosurg Psychiatry1988https://conductscience.org/library/papers/3288717PubMed

See all 21 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
35546942Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives.Front Psychiatry2022https://conductscience.org/library/papers/35546942PubMed
23761715Clozapine associated thrombocytopenia.J Pharmacol Pharmacother2013https://conductscience.org/library/papers/23761715PubMed
16096815The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview.J Neurol2006https://conductscience.org/library/papers/16096815PubMed
15090561Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up.J Neurol Neurosurg Psychiatry2004https://conductscience.org/library/papers/15090561PubMed
12814332Treatment of psychosis in Parkinson's disease: safety considerations.Drug Saf2003https://conductscience.org/library/papers/12814332PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9503276

GET https://conductscience.org/api/papers/v1/9503276/references?page=2